table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 mild to moderate
COVID-19 mild to moderate
ivermectin Bukhari Ahmed Kirti Chachar Babalola Chaccour RIVET-COV ... Espitia-Hernandez Abd-Elsalam Khan Krolewiecki Glorial F Soto-Becerra I-TECH ... Shahbaznejad Spoorthi Mayer
ivermectin plus doxycycline NCT04523831 ...

3 studies excluded by filtering options 2

6083 IFORS (Pott-Junior), 2020 213excludedhigh risk of bias
6625 Nasir, 2020 2310excludednot a RCTrisk of bias not avaialble
7995 Hazan, 2021 2320excludednot a RCTrisk of bias not avaialble

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons